These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 32420682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A variation of the Nijmegen-Bethesda assay using heat or a novel heat/cold pretreatment for the detection of FIX inhibitors in the presence of residual FIX activity.
    Millner AH, Tiefenbacher S, Robinson M, Boesen HT.
    Int J Lab Hematol; 2016 Dec; 38(6):639-647. PubMed ID: 27545696
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Performance evaluation of Revohem™ FVIII chromogenic and Revohem™ FIX chromogenic in the CS-5100 autoanalyser.
    Suzuki A, Suzuki N, Kanematsu T, Shinohara S, Arai N, Kikuchi R, Matsushita T.
    Int J Lab Hematol; 2019 Oct; 41(5):664-670. PubMed ID: 31271527
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Current laboratory practices in the diagnosis and management of haemophilia: a global assessment.
    Kitchen S, Signer-Romero K, Key NS.
    Haemophilia; 2015 Jul; 21(4):550-7. PubMed ID: 25688866
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B.
    Adcock DM, Strandberg K, Shima M, Marlar RA.
    Int J Lab Hematol; 2018 Dec; 40(6):621-629. PubMed ID: 29979821
    [Abstract] [Full Text] [Related]

  • 11. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B.
    Kihlberg K, Strandberg K, Rosén S, Ljung R, Astermark J.
    Haemophilia; 2017 Jul; 23(4):620-627. PubMed ID: 28440032
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one-stage clotting assays.
    Horn C, Négrier C, Kalina U, Seifert W, Friedman KD.
    J Thromb Haemost; 2019 Jan; 17(1):138-148. PubMed ID: 30418692
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey.
    Batty P, Riddell A, Kitchen S, Sardo Infirri S, Walker I, Woods T, Jennings I, Hart DP.
    Haemophilia; 2021 May; 27(3):490-499. PubMed ID: 33650732
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibitors in the Swedish population with severe haemophilia A and B: a 20-year survey.
    Knobe KE, Sjörin E, Tengborn LI, Petrini P, Ljung RC.
    Acta Paediatr; 2002 May; 91(8):910-4. PubMed ID: 12222714
    [Abstract] [Full Text] [Related]

  • 18. Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.
    Boylan B, Rice AS, Neff AT, Manco-Johnson MJ, Kempton CL, Miller CH, Hemophilia Inhibitor Research Study Investigators.
    J Thromb Haemost; 2016 Oct; 14(10):1931-1940. PubMed ID: 27501440
    [Abstract] [Full Text] [Related]

  • 19. Laboratory identification of factor inhibitors: an update.
    Kershaw G, Favaloro EJ.
    Pathology; 2012 Jun; 44(4):293-302. PubMed ID: 22531341
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.